Page last updated: 2024-11-03

ono 1078 and Alzheimer Disease

ono 1078 has been researched along with Alzheimer Disease in 1 studies

pranlukast: SRS-A antagonist; leukotriene D4 receptor antagonist

Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tang, SS1
Hong, H1
Chen, L1
Mei, ZL1
Ji, MJ1
Xiang, GQ1
Li, N1
Ji, H1

Other Studies

1 other study available for ono 1078 and Alzheimer Disease

ArticleYear
Involvement of cysteinyl leukotriene receptor 1 in Aβ1-42-induced neurotoxicity in vitro and in vivo.
    Neurobiology of aging, 2014, Volume: 35, Issue:3

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Caspase 3; Cells, Cultured; Cerebral C

2014